Elicio Therapeutics Inc (ELTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 459 | 827 | 729 | 865 | 0 |
| Cost of Goods | 126 | 348 | 333 | 383 | N/A |
| Gross Profit | 333 | 479 | 396 | 482 | N/A |
| Operating Expenses | 14,309 | 12,412 | 17,998 | 13,434 | 0 |
| Operating Income | -13,850 | -11,585 | -17,269 | -12,569 | N/A |
| Other Income | -15,025 | -6,084 | -3,072 | -653 | 0 |
| Pre-tax Income | -28,875 | -17,669 | -20,341 | -13,222 | 0 |
| Net Income Continuous | -28,875 | -17,669 | -20,341 | -13,222 | N/A |
| Net Income | $-28,875 | $-17,669 | $-20,341 | $-13,222 | $N/A |
| EPS Basic Total Ops | -19.00 | -11.90 | -14.00 | -9.10 | N/A |
| EPS Basic Continuous Ops | -18.99 | -11.90 | -14.01 | -9.14 | N/A |
| EPS Diluted Total Ops | -19.00 | -11.90 | -14.00 | -9.10 | N/A |
| EPS Diluted Continuous Ops | -18.99 | -11.90 | -14.01 | -9.14 | N/A |
| EBITDA(a) | $-8,783 | $-9,257 | $-16,703 | $-12,241 | $N/A |